ArticleMikrochimica acta2026
Dual-readout lateral flow immunoassay based on upconversion nanoparticle-gold nanoparticle luminescence resonance energy transfer for rapid determination of 17β-estradiol.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
A luminescence resonance energy transfer (LRET)-regulated dual-readout lateral flow immunoassay (LFIA) is reported that integrates naked-eye colorimetric screening and near-infrared (NIR)-excited quantitative luminescence analysis on a single test strip. Core-shell upconversion nanoparticles (UCNPs) functionalized with E2-bovine serum albumin conjugates were immobilized on the test line as luminescent donors, while gold nanoparticle (AuNP)-labeled anti-E2 monoclonal antibodies served dually as colorimetric labels and efficient LRET acceptors. Time-resolved luminescence measurements confirmed an LRET efficiency of 18.8%, with the donor lifetime decreasing from 720 to 585 µs upon immunocomplex formation. Under optimized conditions, the assay was completed within 10 min. The luminescence mode exhibited a linear response over 1-500 ng/mL with a limit of detection of 1.37 ng/mL, while the visual mode enabled naked-eye discrimination at 20-40 ng/mL. This UCNP-AuNP LRET strategy provides a practical dual-readout format that balances operational simplicity and quantitative performance, offering a versatile platform for rapid on-site screening of small-molecule contaminants in complex matrices.
Indexed as
Identifiers
42536187What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.